The joint effect of RAD51 rs1801321 and XRCC3 rs861539 (HR pathway) on cancer risk has been previously reported for breast cancer [137], in line with our results, and may be of particular relevance for DTC since the formation of radiation damage-induced RAD51 foci requires functional XRCC3 [138]. This evidence concerns the gene RAD51 and breast cancer.